Spruce Biosciences SPRB
NASDAQ SPRB
$47.34 -1.24 (-2.55%)
As of: Oct 1, 2026 · 12:26 PM EDT

Spruce Biosciences (SPRB) Change in Receivables (2023)

Updated

Spruce Biosciences (SPRB) recorded Change in Receivables of $15 million in Q1 2023.

Analysis

Spruce Biosciences (SPRB) Change in Receivables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Spruce Biosciences 133.73 Mn 133.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 15.00 Mn
API Access

Spruce Biosciences Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=SPRB&period=max&api_key=YOUR_API_KEY